glucuronic acid has been researched along with indomethacin in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (13.64) | 18.2507 |
| 2000's | 7 (31.82) | 29.6817 |
| 2010's | 12 (54.55) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Edelman, ER; Friedman, M; Grossman, W; Harada, K; Sellke, FW; Simons, M; Wang, SY | 1 |
| Imai, T; Otagiri, M; Shiraishi, S | 1 |
| Krishnan, TR; Liu, P | 1 |
| Balasubramaniam, J; Kant, S; Kumar, MT; Pandit, JK | 1 |
| Liu, X; Tong, Z; Wang, C; Ye, S | 1 |
| Alves, NM; Mano, JF; Shi, J | 2 |
| Dai, L; Liu, X; Tong, Z; Wang, C; Ye, S | 1 |
| Cao, S; Liu, L; Mano, JF; Shi, J; Sun, X | 1 |
| Daidoji, T; Hu, M; Kulkarni, KH; Tang, L; Wang, JR; Wang, SW; Yin, T; Yokota, H | 1 |
| Chen, X; Guo, Z; Jiang, W; Li, J; Li, M; Xin, J | 1 |
| Cao, S; Shi, J; Sun, X; Zhang, Z | 1 |
| Işıklan, N; Küçükbalcı, G | 1 |
| Ikeuchi-Takahashi, Y; Onishi, H; Sasatsu, M; Watanabe, N | 1 |
| Tian, K; Xia, X; Xie, C | 1 |
| Cao, S; Shi, J; Sun, X; Xu, X | 1 |
| Coombes, AG; Ma, Y | 1 |
| Itoh, T; Nasu, R; Nishida, R; Yamamoto, A | 1 |
| Díaz-Rodríguez, P; Landin, M | 1 |
| Bijukumar, D; Choonara, BF; Choonara, YE; du Toit, LC; Kumar, P; Murugan, K; Pillay, V | 1 |
| Horibe, S; Kawauchi, S; Mizuno, S; Rikitake, Y; Tanahashi, T | 1 |
| Chokshi, R; Guan, J; Liu, Q; Mao, S; Wu, H; Zhang, X; Zhang, Y | 1 |
22 other study(ies) available for glucuronic acid and indomethacin
| Article | Year |
|---|---|
Basic FGF enhances endothelium-dependent relaxation of the collateral-perfused coronary microcirculation.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Adenosine Diphosphate; Alginates; Animals; Arginine; Calcimycin; Coronary Circulation; Coronary Vessels; Drug Carriers; Endothelium, Vascular; Female; Fibroblast Growth Factor 2; Glucuronic Acid; Heart; Hexuronic Acids; Indomethacin; Ketanserin; Male; Microcirculation; Muscle Relaxation; Myocardial Infarction; Myocardium; Nitroarginine; Nitroprusside; Potassium Chloride; Prostaglandin Endoperoxides, Synthetic; Sepharose; Serotonin; Swine; Thromboxane A2; Vasodilation | 1994 |
Controlled-release preparation of indomethacin using calcium alginate gel.
Topics: Administration, Oral; Adult; Alginates; Animals; Chromatography, High Pressure Liquid; Delayed-Action Preparations; Dogs; Drug Carriers; Gels; Glucuronic Acid; Hexuronic Acids; Humans; Indomethacin; Intestinal Absorption; Male; Molecular Weight; Solubility | 1993 |
Alginate-pectin-poly-L-lysine particulate as a potential controlled release formulation.
Topics: Adhesiveness; Alginates; Animals; Caco-2 Cells; Capsules; Chlorothiazide; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Drug Delivery Systems; Gelatin; Glucuronic Acid; Hexuronic Acids; Humans; Hydrogen-Ion Concentration; Indomethacin; Male; Microscopy, Electron, Scanning Transmission; Particle Size; Pectins; Polylysine; Rats; Rats, Wistar; Theophylline; Time Factors | 1999 |
In vitro and in vivo characterization of scleral implants of indomethacin.
Topics: Alginates; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemical Phenomena; Chemistry, Physical; Cross-Linking Reagents; Drug Carriers; Drug Implants; Freezing; Glucuronic Acid; Hexuronic Acids; Hydrogen-Ion Concentration; Indomethacin; Particle Size; Rabbits; Sclera | 2001 |
Deposition temperature effect on release rate of indomethacin microcrystals from microcapsules of layer-by-layer assembled chitosan and alginate multilayer films.
Topics: Alginates; Capsules; Chitosan; Crystallization; Delayed-Action Preparations; Diffusion; Glucuronic Acid; Hexuronic Acids; Hydrogen-Ion Concentration; Indomethacin; Sodium Chloride; Solubility; Temperature | 2005 |
Drug release of pH/temperature-responsive calcium alginate/poly(N-isopropylacrylamide) semi-IPN beads.
Topics: Acrylic Resins; Alginates; Biocompatible Materials; Delayed-Action Preparations; Drug Carriers; Glucuronic Acid; Hexuronic Acids; Hydrogels; Hydrogen-Ion Concentration; In Vitro Techniques; Indomethacin; Materials Testing; Temperature | 2006 |
Enhanced resistance of polyelectrolyte multilayer microcapsules to pepsin erosion and release properties of encapsulated indomethacin.
Topics: Alginates; Anti-Inflammatory Agents, Non-Steroidal; Capsules; Chitosan; Delayed-Action Preparations; Drug Delivery Systems; Electrolytes; Glucuronic Acid; Hexuronic Acids; Indomethacin; Microscopy, Atomic Force; Pepsin A; Polysaccharides | 2007 |
Chitosan coated alginate beads containing poly(N-isopropylacrylamide) for dual-stimuli-responsive drug release.
Topics: Acrylamides; Acrylic Resins; Alginates; Anti-Inflammatory Agents, Non-Steroidal; Chitosan; Coated Materials, Biocompatible; Delayed-Action Preparations; Drug Carriers; Glucuronic Acid; Hexuronic Acids; Indomethacin; Microspheres; Polymers; Spectroscopy, Fourier Transform Infrared | 2008 |
Biomineralized polysaccharide beads for dual-stimuli-responsive drug delivery.
Topics: Acrylic Resins; Alginates; Delayed-Action Preparations; Drug Delivery Systems; Glucuronic Acid; Hexuronic Acids; Hydrogen-Ion Concentration; Indomethacin; Microscopy, Electron, Scanning; Microspheres; Polysaccharides; Spectroscopy, Fourier Transform Infrared; Temperature | 2008 |
Disposition of flavonoids via enteric recycling: UDP-glucuronosyltransferase (UGT) 1As deficiency in Gunn rats is compensated by increases in UGT2Bs activities.
Topics: Animals; Anticholesteremic Agents; Apigenin; Azetidines; Bile; Camptothecin; Enzyme Inhibitors; Ezetimibe; Flavonoids; Genistein; Glucuronic Acid; Glucuronosyltransferase; Indomethacin; Intestinal Absorption; Intestinal Mucosa; Irinotecan; Isoflavones; Liver; Male; Microsomes; Microsomes, Liver; Protein Isoforms; Rats; Rats, Gunn; Rats, Wistar; Recombinant Proteins; Testosterone; Up-Regulation | 2009 |
Study of branched cationic beta-cyclodextrin polymer/indomethacin complex and its release profile from alginate hydrogel.
Topics: Adamantane; Alginates; Anti-Inflammatory Agents, Non-Steroidal; beta-Cyclodextrins; Calorimetry, Differential Scanning; Cations; Chemistry, Pharmaceutical; Choline; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Epichlorohydrin; Glucuronic Acid; Hexuronic Acids; Hydrogels; Hydrophobic and Hydrophilic Interactions; Indomethacin; Kinetics; Magnetic Resonance Spectroscopy; Molecular Conformation; Solubility; Technology, Pharmaceutical | 2010 |
Biomineralized hydrophobically modified alginate membrane for sustained drug delivery.
Topics: Acrylamides; Acrylic Resins; Alginates; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Glucuronic Acid; Hexuronic Acids; Hydrophobic and Hydrophilic Interactions; Indomethacin; Kinetics; Membranes, Artificial; Microscopy, Electron, Scanning; Palmitic Acid; Polymers; Solubility; Spectroscopy, Fourier Transform Infrared; Technology, Pharmaceutical | 2011 |
Microwave-induced synthesis of alginate-graft-poly(N-isopropylacrylamide) and drug release properties of dual pH- and temperature-responsive beads.
Topics: Acrylamides; Acrylic Resins; Alginates; Drug Delivery Systems; Glucuronic Acid; Glutaral; Hexuronic Acids; Hydrochloric Acid; Hydrogel, Polyethylene Glycol Dimethacrylate; Hydrogen-Ion Concentration; Imidazoles; Indomethacin; Kinetics; Microwaves; Particle Size; Phase Transition; Polymers; Solutions; Temperature | 2012 |
Formulation and evaluation of matrix type mucoadhesive tablets aimed at treating oral aphtha.
Topics: Adhesiveness; Alginates; Anti-Inflammatory Agents, Non-Steroidal; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Delayed-Action Preparations; Glucuronic Acid; Hexuronic Acids; Humans; Indomethacin; Mouth Mucosa; Solubility; Stomatitis, Aphthous; Tablets; Tensile Strength; X-Ray Diffraction | 2013 |
Chitosan/alginate multilayer film for controlled release of IDM on Cu/LDPE composite intrauterine devices.
Topics: Alginates; Chitosan; Copper; Drug Delivery Systems; Glucuronic Acid; Hexuronic Acids; Indomethacin; Molecular Structure; Organometallic Compounds; Polyethylene; Surface Properties | 2013 |
Chitosan coated alginate/poly(N-isopropylacrylamide) beads for dual responsive drug delivery.
Topics: Acrylamides; Acrylic Resins; Alginates; Chitosan; Drug Carriers; Glucuronic Acid; Hexuronic Acids; Hydrogels; Hydrogen-Ion Concentration; Indomethacin; Kinetics; Microscopy, Electron, Scanning; Microspheres; Particle Size; Polymers; Polyphosphates; Spectroscopy, Fourier Transform Infrared; Temperature | 2013 |
Designing colon-specific delivery systems for anticancer drug-loaded nanoparticles: an evaluation of alginate carriers.
Topics: Alginates; Antineoplastic Agents; Colon; Colonic Neoplasms; Drug Carriers; Drug Delivery Systems; Glucuronic Acid; Hexuronic Acids; Humans; Indomethacin; Nanoparticles; Polymethacrylic Acids | 2014 |
Sodium alginate ameliorates indomethacin-induced gastrointestinal mucosal injury via inhibiting translocation in rats.
Topics: Alginates; Anemia; Animals; Anti-Ulcer Agents; Atrophy; Bacterial Translocation; Biomarkers; Capillary Permeability; Catalase; Cytoprotection; Disease Models, Animal; Enteritis; Gastric Mucosa; Glucuronic Acid; Glutathione Peroxidase; Hexuronic Acids; Indomethacin; Intestinal Mucosa; Intestine, Small; Male; Peroxidase; Rats, Sprague-Dawley; Stomach Ulcer; Superoxide Dismutase | 2014 |
Controlled release of indomethacin from alginate-poloxamer-silicon carbide composites decrease in-vitro inflammation.
Topics: Alginates; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbon Compounds, Inorganic; Cell Line; Ceramics; Chondrocytes; Collagen; Cytokines; Delayed-Action Preparations; Drug Liberation; Extracellular Matrix; Glucuronic Acid; Hexuronic Acids; Humans; Indomethacin; Inflammation; Macrophages; Mice; Osteoarthritis; Poloxamer; Silicon Compounds; Solubility | 2015 |
Design of an Inflammation-Sensitive Polyelectrolyte-Based Topical Drug Delivery System for Arthritis.
Topics: Administration, Topical; Alginates; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cellulose; Chemistry, Pharmaceutical; Chitosan; Drug Carriers; Drug Delivery Systems; Drug Liberation; Gels; Glucuronic Acid; Hexuronic Acids; Hyaluronic Acid; Indomethacin; Inflammation; Membranes; Nanoparticles; Particle Size; Permeability; Polyelectrolytes; Pyrrolidonecarboxylic Acid | 2016 |
Preventative Effects of Sodium Alginate on Indomethacin-induced Small-intestinal Injury in Mice.
Topics: Alginates; Animals; Disease Models, Animal; Gastrointestinal Motility; Glucuronic Acid; Hexuronic Acids; Humans; Indomethacin; Intestinal Mucosa; Intestine, Small; Mice; Stomach Ulcer | 2016 |
Alginate as a potential diphase solid dispersion carrier with enhanced drug dissolution and improved storage stability.
Topics: Alginates; Drug Carriers; Drug Liberation; Drug Stability; Drug Storage; Glucuronic Acid; Hexuronic Acids; Indomethacin; Lovastatin; Solubility | 2018 |